Validation Data Gallery
Filter:
Tested Applications
Positive WB detected in | human plasma |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Published Applications
KD/KO | See 1 publications below |
WB | See 1 publications below |
Product Information
20269-1-AP targets Factor XIIIb in WB, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Peptide 相同性解析による交差性が予測される生物種 |
Full Name | coagulation factor XIII, B polypeptide |
Calculated molecular weight | 76 kDa |
Observed molecular weight | ~80 kDa |
GenBank accession number | NM_001994 |
Gene Symbol | Factor XIIIb |
Gene ID (NCBI) | 2165 |
RRID | AB_3085601 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
UNIPROT ID | P05160 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
Coagulation factor XIII (FXIII) is a blood proenzyme that catalyzes intermolecular cross-linking of fibrinogen and is involved in the clotting cascade. Factor XIII is composed of two catalytic FXIIIa and two protective/regulatory FXIIIb subunits. FXIIIb is the carrier/regulatory protein of its partner FXIIIa subunit.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for Factor XIIIb antibody 20269-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Biomol Biomed F13B regulates angiogenesis and tumor progression in hepatocellular carcinoma via the HIF-1α/VEGF pathway
|